Poultry Diagnostics Market Insights, Research and Growth Factor till 2033

The global Poultry Diagnostics Market demand is estimated to develop at a moderate rate of 10.5% during the forecast period. In 2023, the Poultry Diagnostics market is expected to be worth $590 million. The Poultry Diagnostics sector is anticipated to be worth US$ 1.6 billion by 2033.

Poultry disease outbreaks and growing frequencies of zoonotic illnesses are expected to have an impact on the Poultry Diagnostics market growth in the future years. The creation of animal health information portals, particularly in developed countries, is likely to boost growth during the forecast period. Data from veterinary hospitals can be uploaded to the internet and distributed to other researchers and professionals. The adoption of this service is expected to result in ongoing changes in sickness prevalence. This allows for continuous communication, which aids the owner in remembering preventative diagnosis, routine vaccination, the type of immunisation to be provided, medicine refills, and dietary instructions.

Increasing government actions to promote animal health products are expected to drive market growth overall throughout the forecast period. According to the United Nations Department of Economic and Social Affairs, there are currently over 7.3 billion people on the planet, with 9.7 billion anticipated to reside there by 2050.

Competitive Landscape:

The Poultry Diagnostics market is distributed globally owing to domestic and foreign competitors. Several companies command substantial market shares in their respective specialty areas. Large businesses often give natural events like product approvals and the rising incidence of zoonotic and poultry illnesses a high priority. These elements are anticipated to propel the global market for Poultry Diagnostics to grow quickly.

Key Players:

  • Agrobiotek Internacional
  • Affinitech Ltd.
  • Biochek
  • Bioingentech Biotechnologies Inc.
  • Bionote Inc.
  • Boehringer Ingelheim GmbH
  • GD Animal Health
  • Idexx Laboratories Inc.
  • IDVet
  • Megacor Diagnostik GmbH
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Zoetis Inc.
  • Bioneer Corporation

Browse More@ https://www.futuremarketinsights.com/reports/poultry-diagnostics-market

Key Segments Profiled in the Poultry Diagnostics Market Survey

By Test Type:

  • ELISA Test
  • PCR Test

By Disease:

  • Avian Salmonellosis
  • Avian Influenza
  • Newcastle Disease
  • Avian Mycoplasmosis
  • Avian Pasteurellosis
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Avian Encephalomyelitis
  • Avian Reovirus
  • Chicken Anemia

By Services:

  • Bacteriology
  • Virology
  • Parasitology

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more